Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy
New England Journal of Medicine · 13.03.2025 · 392 (11) · 1138-1140
DOI: 10.1056/nejmc2300802 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 13.03.2025. Verfasst von Richard S Finkel und 8 weiteren Autor:innen. Beteiligte Einrichtung: St. Jude Children's Research Hospital, Memphis, TN. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- St. Jude Children's Research Hospital, Memphis, TN.
- OBGYN Partners of Augusta, Augusta, GA.
- F. Hoffmann-La Roche, Basel, Switzerland.
Zitieren
APA
Finkel, R. S., Hughes, S. H., Parker, J., Civitello, M., Lavado, A., Mefford, H. C., Mueller, L., Kletzl, H., & Prenatal SMA Risdiplam Study Group (2025). Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy. New England Journal of Medicine, 392(11), 1138-1140. https://doi.org/10.1056/nejmc2300802
Vancouver
Finkel RS, Hughes SH, Parker J, Civitello M, Lavado A, Mefford HC, et al. Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy. New England Journal of Medicine. 2025;392(11):1138-1140. doi:10.1056/nejmc2300802
BibTeX
@article{Finkel2025,
author = {Finkel, Richard S and Hughes, Samuel H and Parker, JulieAnn and Civitello, Matthew and Lavado, Alfonso and Mefford, Heather C and Mueller, Lutz and Kletzl, Heidemarie and Prenatal SMA Risdiplam Study Group, Prenatal SMA Risdiplam Study Group},
title = {Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {11},
pages = {1138--1140},
doi = {10.1056/nejmc2300802}
}
EUVIMED